FDA designates Class 1 recalls for aspiration catheter, infusion accessory, endotracheal tubes
Editor's Note The US Food and Drug Administration (FDA) has issued three Class I medical device recalls—the most severe category indicating risk of serious injury or death—for Q’Apel Medical Inc.’s HIPPO 072 Aspiration System and Cheetah catheter, Fresenius Kabi USA’s Blood Products Administration Set with 200 Micron Filter, and Medline…
Revised sterilization standards demand urgent attention from perioperative leaders
Editor's Note New and revised sterilization and reprocessing standards are reshaping the landscape for sterile processing departments, placing greater emphasis on chemical modalities, device-specific protocols, and system-wide quality management, according to the Healthcare Purchasing News May 27 update on compliance and standards. Among the most significant developments is the overhaul…
Study: Language barriers raise sepsis death risk despite faster treatment
Editor's Note Patients hospitalized with sepsis who have limited English proficiency (LEP) face significantly higher odds of dying in the hospital even after accounting for multiple demographic and clinical factors, according to research presented at the American Thoracic Society International Conference by researchers from UC San Diego. Healio reported the…
New guidelines address critical airway challenges in obese surgical patients
Editor's Note A multidisciplinary expert panel has released the first evidence-based airway management guidelines specific to patients living with obesity. Published June 5 in Anaesthesia, the 43-point framework—developed by the Society of Obesity and Bariatric Anaesthesia (SOBA)—offers perioperative strategies aimed at improving the safety and consistency of care in a…
FDA designates Class 1 recalls for intraoperative positioning guidewires, infusion pumps, dialysate
Editor's Note Centerline Biomedical’s recall of IOPS Guidewire ATW-2, Zyno Medical’s recall of Z-800 series infusion pumps, and Nipro’s recall of MedicaLyte Liquid Bycarbonate Concentrate have been designated by the US Food and Drug Administration (FDA) as Class 1, the most serious designation indicating risk of severe injury or death.…
New GLP-1 guidance urges longer fasting before anesthesia
Editor's Note Patients taking GLP-1 receptor agonists (GLP-1 RAs) do not need to discontinue these medications before undergoing anesthesia but should follow extended preoperative fasting protocols to reduce aspiration risk, according to a June 5 article in Medscape. As detailed in the article, this recommendation comes from a new multidisciplinary…
‘SMART Toolkit’ empowers healthcare leaders with actionable strategies to reduce HAIs
Editor's Note A new digital resource is helping hospital leaders strengthen infection prevention efforts by focusing not just on bedside protocols, but on management strategies proven to reduce healthcare-associated infections (HAIs). The “SMART Toolkit,” developed by researchers at The Ohio State University and launched in July 2022, offers a free,…
Significant CMS moves include withdrawal of emergency abortion care guidance
Editor's Note CMS has rescinded a 2022 guidance that protected clinicians providing emergency abortion care under the Emergency Medical Treatment & Labor Act (EMTALA), removing a key federal safeguard for providers in states with abortion restrictions, according to a June 2 article in Becker’s Hospital Review. The guidance, originally issued…
Partnership with Epic fuels ASA’s push for smarter, safer anesthesia
Editor's Note The American Society of Anesthesiologists (ASA) has partnered with Epic to launch the Anesthesia Community Registry (ACR), which is designed to enable easier data collection, benchmarking, and insight generation at scale. Powered by Epic’s new Community Registries platform, the ACR will complement ASA’s existing National Anesthesia Clinical Outcomes…
Study: Blood test detects colorectal cancer but misses most precancerous polyps
Editor's Note A new blood test shows promise in detecting colorectal cancer—the second leading cause of cancer deaths in the US—but was less effective at identifying precancerous polyps, according to a June 2 announcement from Kaiser Permanente. Not yet approved by the US Food and Drug Administration, the test is…
Free Daily News
- Back to Business: Budgeting for Sustainable Staffing Models in the OR
- Healthcare job gain in August offset by losses in federal government, other industries
- AHA study: HOPD Medicare patients are poorer, sicker, more rural than those seen in physician offices
- ACS, Lifesaving Technologies launch nationwide effort to expand bleeding control readiness
- Minimally invasive ICH surgery evacuates clot fast but fails to improve 6-month outcomes
- Rural hospitals face crisis under OBBBA as experts call for cohesive reform
- AMA urges health systems to act now on AI governance
- Suicide Prevention Month: Hospitals prepare for new The Joint Commission suicide prevention goal, effective 2026
- Survey: Perioperative leaders adapt to supply strain, staffing pressure, ASC growth
- Gait retraining eases knee osteoarthritis pain as effectively as medication, can delay knee surgery